Información de la revista
Vol. 58. Núm. 3.
Páginas 143-144 (marzo 2011)
Vol. 58. Núm. 3.
Páginas 143-144 (marzo 2011)
Scientific letter
Acceso a texto completo
Metastatic adenopathy from a thyroid microcarcinoma: final diagnosis of a presumed paragangliomar
Adenopatía metastásica de un microcarcinoma tiroideo, diagnóstico final de un supuesto para ganglioma
Visitas
1464
Mariela Varsavsky, María Cortés Berdonces
, Guillermo Alonso, Antonia García Martín, Manuel Muñoz Torres
Autor para correspondencia
Servicio de Endocrinología y Nutrición, Hospital Universitario San Cecilio, Granada, Spain
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
C. ooper, D. Doherty, G. Haugen, B. Kloos, R. Lee, S. Mandel, Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer, et al.
The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer.
Thyroid, 19 (2009), pp. 1167-1214
[2.]
R. Görges, G. Kahaly, J. Muller-Brand, H. Mäcke, H.W. Roser, A. Bockisch.
Radionuclide-labeled somatostatin analogues for diagnostic and therapeutic purposes in nonmedullary thyroid cancer.
Thyroid, 11 (2001), pp. 647-659
[3.]
J.J. Teunissen, D.J. Kwekkeboom, E.P. Krenning.
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs.
Trend Endocrinol Metab, 17 (2006), pp. 19-25
[4.]
N.J. Sarlis, L. Gourgiotis, L.C. Guthrie, B. Galen, M.C. Skarulis, T.H. Shawker, et al.
In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer comparison with F-18 FDG positron emission tomography and extensive conventional radiographic image.
Clin Nucl Med, 28 (2003), pp. 208-217
[5.]
R.J. Robbins, R.H. Hill, G.W. Wang, H.H. Macapinlac, S.M. Larson.
Inhibition of metabolic activity in papillary thyroid carcinoma by a somatostatin analogue.
Thyroid, 10 (2000), pp. 177-183
[6.]
S. Krantic.
Peptides as regulators of the immune system: emphasis on somatostatin.
Peptides, 21 (2000), pp. 1941-1964
[7.]
D.J. Kwekkeboom, J. Mueller-Brand, G. Paganelli, L.B. Anthony, S. Pawels, L.K. Kvols, et al.
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
J Nucl Med, 46 (2005), pp. S62-S66
Copyright © 2011. Sociedad Española de Endocrinología y Nutrición